Company news
Adherium Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Notice of Annual General Meeting/Proxy Form
October 26, 2023
Annual Report to shareholders
August 30, 2023
Adherium SPP and Shortfall Offers Prospectus
November 17, 2022
Adherium secures $13.5m in placement commitments
September 16, 2022
Adherium signs UK distribution agreement with Helicon Health
June 14, 2022
Adherium to support Avillion sponsored clinical study
June 1, 2022
Adherium awarded US-based AZ clinical study supply contract
September 24, 2021
Target's Statement
June 28, 2021
Letter to Shareholders re takeover offer
June 16, 2021
Adherium submits next gen sensor for US FDA clearance
May 31, 2021
Replacement Bidders Statement
May 27, 2021
1st Supplementary Bidder's Statement(marked up replacement
May 27, 2021
Adherium announces new CEO and Board appointments
May 12, 2021
Adherium Directors' Statement re Takeover
May 10, 2021
Appendix 4C - quarterly
April 30, 2021
Adherium response to Respiri announcement
April 29, 2021
Bidder's Statement
April 29, 2021
Adherium investor presentation
March 17, 2021
Adherium secures $18m share placement commitment
March 17, 2021
Adherium agrees rollout to specialist US respiratory centres
November 23, 2020
Adherium secures $3m funding from Viburnum
October 25, 2020
CEO update presentation to the EGM
July 23, 2020
Adherium $5m raise with BioScience Managers Translation Fund
May 25, 2020
Adherium progresses US sales agreement with Monaghan Medical
April 29, 2020
Adherium appoints Mike Motion CEO/Director and Anne Bell CFO
April 24, 2020
Adherium and Planet Innovation partner in tech development
April 21, 2020
Adherium announces collaboration with HGE Health in COPD
April 16, 2020
Adherium Completes $5.4m Capital Raise
February 10, 2020
Adherium December 2019 Update Presentation
December 18, 2019
Adherium Non-renounceable Rights Issue Offer Document
December 18, 2019
Adherium announces Non-Renounceable Issue
December 10, 2019
Adherium appoints Peter Stratford CEO and Mike Motion CCO
November 21, 2019
Adherium and Patients Know Best strategic collaboration
November 17, 2019
Amended - Adherium announces $1.1m notes financing
November 11, 2019
Response to ASX Query
November 10, 2019
Adherium announces $1.8m secured notes financing
August 21, 2019
Adherium and Summatix announce strategic initiative
August 20, 2019
Adherium Receives further U.S. 510k Clearances
July 15, 2019
Employee Share Plan buy-back - Appendix 3C
May 24, 2019
Response to Appendix 4C Query
May 6, 2019
Adherium Restructures for Growth
December 12, 2018
Adherium Investor Conference Call Presentation
October 30, 2018
Adherium Announces Q1 Fiscal Year 2019 Investor Conference Call
October 25, 2018
Adherium and Vitalus Health Launch Commercial Program
August 23, 2018
Adherium Launches Hailie™ Solution Direct-to-Consumer in the U.S. for Better Asthma and COPD Management
August 13, 2018
Adherium Receives Additional US FDA 510(k) Clearance
July 26, 2018
Adherium Program with Connecticut Childrens Medical Center
July 10, 2018
Adherium Smartinhaler used in Global Mild-Asthma Studies
May 21, 2018
Adherium launches new global brand Hailie
May 16, 2018
Adherium Announces Program with Vitalus Health
May 1, 2018
Decks
The 5 newest of 31 decks. Every deck is listed under its year.
- Investor Presentation (July 2026)
Investor deck · 24 slides · July 2026
- Investor Webinar June 2026
Conference · 19 slides · June 2026
- Investor Presentation (February 2026)
Investor deck · 42 slides · Feb 16, 2026
- Investor Presentation (February 2026)
Investor deck · 36 slides · February 2026
- Investor Webinar (December 2025)
Conference · 15 slides · Dec 1, 2025